Whereas lung cancer is the leading cause of cancer-related death among individuals in the United States, accounting for more deaths than colon cancer, breast cancer, and prostate cancer combined; Whereas, in 2023, an estimated 238,340 individuals in the United States will be diagnosed with lung cancer, and 127,070 individuals (approximately 350 individuals per day) will die from the disease; Whereas 1 in 16 men and 1 in 17 women in the United States will develop lung cancer during their lifetimes; Whereas the rate of lung cancer death in women in the United States has increased by 92 percent over the 50-year span from 1971 to 2021; Whereas, each year, more women die from lung cancer than breast cancer and ovarian cancer combined; Whereas, in 2023, 20,500 people will die from lung cancer unrelated to smoking, which would be the eighth leading cause of cancer death if classified as a separate disease; Whereas 18 percent of lung cancers are unrelated to smoking, and the proportion of lung cancers diagnosed in individuals who have never smoked is increasing in the United States; Whereas, in 2023, approximately 103,000 of the 127,070 lung cancer deaths (81 percent) will be caused by cigarette smoking directly, with an additional 3,560 lung cancer deaths caused by second-hand smoke; Whereas the 5-year survival rate for localized lung cancer is 63 percent, yet a majority of lung cancers are diagnosed at a distant stage, for which the 5-year survival rate is 8 percent; Whereas screening with low-dose computed tomography can detect lung cancer in its earliest stages and ultimately save lives, yet only 3 to 7 percent of individuals in the United States at high risk for lung cancer undergo lung cancer screening; Whereas geographic availability of facilities and transportation barriers are persistent challenges to lung cancer screening; Whereas nearly 70 percent of adults are not familiar with lung cancer screening and the low-dose computed tomography scan